Nivolumab is a targeted therapy drug and the generic name of Opdivo. Currently, nivolumab has received approval for various indications such as unresectable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC), advanced renal cell cancer, classical Hodgkin’s lymphoma (cHL), and recurrent or metastatic squamous cell carcinoma.
Nivolumab Drugs Market: Introduction
- Nivolumab is a targeted therapy drug and the generic name of Opdivo. Currently, nivolumab has received approval for various indications such as unresectable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC), advanced renal cell cancer, classical Hodgkin’s lymphoma (cHL), and recurrent or metastatic squamous cell carcinoma.
- It is administered intravenously every two weeks. The amount of nivolumab administered depends on various factors such as type of condition and general health of the patient.
Read Report Overview - https://www.transparencymarketresearch.com/nivolumab-drugs-market.html
Key Drivers, Restrains, and Opportunities of Global Nivolumab Drugs Market
- Higher incidence of non-small cell lung cancer (NSCLC) is expected to drive the nivolumab drugs market during the forecast period. According to the American Cancer Society’s estimates, approximately 235,760 new cases were diagnosed and 131,880 person died from lung cancer in 2020, in the U.S. In general, about 84% lung cancer cases are non-small cell lung cancer (NSCLC).
- Approval of nivolumab for newer indications is also anticipated to further boost the market during the forecast period. For instance, on January 22, 2021, USFDA approved a combination of cabozantinib and nivolumab for the treatment of advanced renal cell carcinoma.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81807
North America to Capture Major Share of Global Nivolumab Drugs Market
- North America is expected to account for a major share of the global nivolumab drugs market due to higher incidence of advanced renal cell carcinoma, classical Hodgkin’s lymphoma (cHL), and recurrent or metastatic squamous cell carcinoma in the region. Moreover, high disposable income and increasing healthcare expenditure are anticipated to drive the market in the region.
- The nivolumab drugs market in Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in the prevalence of metastatic non-small cell lung cancer (NSCLC) in the region
Pre Book Nivolumab Drugs Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=81807<ype=S
Key Players Operating in Global Nivolumab Drugs Market
Nivolumab is a patented drug under the brand Opdivo
Major players operating in the global nivolumab drugs market are listed below:
- Bristol-Myers Squibb Company
More Trending Reports by Transparency Market Research:
Dental Removal Instrument Market: A wide selection of dental instruments and dental tools are manufactured by reputable companies in the dental industry. These products include scalers, curettes, serrated cotton pliers, dental mirrors, and surgical instrument cleaners for the removal of dental implants. These devices are used to examine teeth for decay, calculus, furcations, and other abnormalities. Explorers are utilized to explore the mouth and find issues that might be troubling the patient.
Artificial Disc Replacement Market: Surge in different sports-related injuries and trauma-related injuries across the globe is projected to push the sales opportunities in the global artificial disc replacement market in the forecast period 2021–2031. Apart from this, increased number of orthopedic surgeries is one of the key factors fueling demand avenues in the market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/